2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole

C25H32N6O — CID 154620190

IUPAC2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole
SMILESCOc1cccnc1[C@@H]1CCC[C@H](c2nc3c(N4CCN(C)C5(CC5)C4)cccc3[nH]2)N1
InChIInChI=1S/C25H32N6O/c1-30-14-15-31(16-25(30)11-12-25)20-9-4-7-17-22(20)29-24(28-17)19-8-3-6-18(27-19)23-21(32-2)10-5-13-26-23/h4-5,7,9-10,13,18-19,27H,3,6,8,11-12,14-16H2,1-2H3,(H,28,29)/t18-,19+/m0/s1
InChIKeyFKDRMPXVZJLQAJ-RBUKOAKNSA-N
MW432.57 g/mol
LogP3.81
Rot. Bonds4

About 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole

2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole (PubChem CID 154620190) has the molecular formula C25H32N6O and a molecular weight of 432.57 g/mol. Its IUPAC name is 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole.

Molecular Properties

Compound Name2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole
PubChem CID154620190
Molecular FormulaC25H32N6O
Molecular Weight432.57 g/mol
Exact Mass432.26
IUPAC Name2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole
SMILESCOc1cccnc1[C@@H]1CCC[C@H](c2nc3c(N4CCN(C)C5(CC5)C4)cccc3[nH]2)N1
InChIInChI=1S/C25H32N6O/c1-30-14-15-31(16-25(30)11-12-25)20-9-4-7-17-22(20)29-24(28-17)19-8-3-6-18(27-19)23-21(32-2)10-5-13-26-23/h4-5,7,9-10,13,18-19,27H,3,6,8,11-12,14-16H2,1-2H3,(H,28,29)/t18-,19+/m0/s1
InChIKeyFKDRMPXVZJLQAJ-RBUKOAKNSA-N
XLogP3.81
TPSA69.31 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500432.57
LogP ≤ 53.81
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole?
The IUPAC name of 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole (CID 154620190) is 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole.
What is the SMILES notation for 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole?
The canonical SMILES for 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole is COc1cccnc1[C@@H]1CCC[C@H](c2nc3c(N4CCN(C)C5(CC5)C4)cccc3[nH]2)N1.
What is the InChIKey of 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole?
The InChIKey is FKDRMPXVZJLQAJ-RBUKOAKNSA-N. The full InChI is InChI=1S/C25H32N6O/c1-30-14-15-31(16-25(30)11-12-25)20-9-4-7-17-22(20)29-24(28-17)19-8-3-6-18(27-19)23-21(32-2)10-5-13-26-23/h4-5,7,9-10,13,18-19,27H,3,6,8,11-12,14-16H2,1-2H3,(H,28,29)/t18-,19+/m0/s1.
What are the key properties of 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole?
2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole has a molecular weight of 432.57 g/mol, XLogP of 3.81, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2R,6S)-6-(3-methoxy-2-pyridinyl)piperidin-2-yl]-4-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)-1H-benzimidazole is sourced from PubChem (CID 154620190), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).